Baxarias Marta, Jornet-Rius Oriol, Donato Giulia, Mateu Cristina, Alcover Mª Magdalena, Pennisi Maria Grazia, Solano-Gallego Laia
Departament de Medicina i Cirurgia Animals, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
Dipartimento di Scienze Veterinarie, Università di Messina-Polo Universitario Annunziata, 98168 Messina, Italy.
Animals (Basel). 2023 May 16;13(10):1649. doi: 10.3390/ani13101649.
Canine leishmaniosis caused by is a disease with a wide range of clinical manifestations. Epidemiological serosurveys performed in Europe often lack a thorough assessment of clinical health status of studied dogs. The aim of this study was to evaluate signalment, immunological and parasitological status and clinicopathological findings of -seropositive apparently healthy dogs (n = 212) living in endemic areas. Routine laboratory tests, endpoint in-house ELISA to quantify the anti- antibodies, blood qPCR and IFN-γ ELISA were performed. All dogs enrolled were -seropositive and were classified as healthy (n = 105) or sick (n = 107) according to LeishVet guidelines. The sick group presented a higher proportion of medium to high antibody levels and positive qPCR and lower IFN-γ concentration compared to the healthy group. Sick dogs were mostly classified in LeishVet stage IIa. Biochemical alterations (98%) were the most common clinicopathological findings, with fewer urinary tract (46%) and hematological (40%) alterations. Apparently healthy -seropositive dogs can be classified between truly healthy dogs and sick dogs with clinicopathological findings. Sick dogs presented medium to high seropositivity and parasitemia and low IFN-γ concentrations, and their most common clinicopathological abnormalities were serum protein alterations followed by proteinuria and lymphopenia.
由[病原体名称未给出]引起的犬利什曼病是一种具有广泛临床表现的疾病。在欧洲进行的流行病学血清学调查往往缺乏对所研究犬只临床健康状况的全面评估。本研究的目的是评估生活在流行地区的[病原体名称未给出]血清阳性但看似健康的犬只(n = 212)的特征、免疫和寄生虫学状况以及临床病理结果。进行了常规实验室检查、用于定量抗[抗体名称未给出]抗体的终点内部酶联免疫吸附测定(ELISA)、血液定量聚合酶链反应(qPCR)和干扰素-γ ELISA。所有纳入的犬只均为[病原体名称未给出]血清阳性,并根据利什曼病兽医指南分为健康组(n = 105)或患病组(n = 107)。与健康组相比,患病组呈现出更高比例的中到高抗体水平和qPCR阳性,以及更低的干扰素-γ浓度。患病犬大多被归类为利什曼病兽医指南中的IIa期。生化改变(98%)是最常见的临床病理结果,尿路改变(46%)和血液学改变(40%)较少。看似健康的[病原体名称未给出]血清阳性犬可分为真正健康的犬只和具有临床病理结果的患病犬只。患病犬呈现出中到高血清阳性率和寄生虫血症以及低干扰素-γ浓度,其最常见的临床病理异常是血清蛋白改变,其次是蛋白尿和淋巴细胞减少。